The effect of medial pulvinar stimulation on temporal lobe seizures.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
04 2019
Historique:
received: 23 11 2018
revised: 02 01 2019
accepted: 29 01 2019
pubmed: 16 2 2019
medline: 14 4 2020
entrez: 16 2 2019
Statut: ppublish

Résumé

We investigated the effect of electrical stimulation of the medial pulvinar (PuM) in terms of its effect on temporal lobe seizures. Eight patients with drug-resistant temporal lobe epilepsy undergoing stereoelectroencephalographic exploration were included. All had at least one electrode exploring the PuM. High-frequency (50 Hz) stimulations of the PuM were well tolerated in the majority of them. During diagnostic stimulation to confirm the epileptogenic zone, 19 seizures were triggered by stimulating the hippocampus. During some of these seizures, ipsilateral pulvinar stimulation was applied (130 Hz, pulse width = 450 microseconds, duration = 3-7 seconds, 1-2 mA). Compared to non-PuM-stimulated seizures, five of eight patients experienced clinically less severe seizures, particularly in terms of degree of alteration of consciousness. On the electrical level, seizures were more rapidly clonic with a shorter tonic phase. This proof of concept study is the first to suggest that PuM stimulation could be a well-tolerated and effective means of therapeutic deep brain stimulation in drug-resistant epilepsies.

Identifiants

pubmed: 30767195
doi: 10.1111/epi.14677
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25-e30

Informations de copyright

Wiley Periodicals, Inc. © 2019 International League Against Epilepsy.

Auteurs

Cristina Filipescu (C)

Clinical Neurophysiology and Epileptology Department, Timone Hospital, Assitance Publique Hôpitaux de Marseille, Marseille, France.

Stanislas Lagarde (S)

Clinical Neurophysiology and Epileptology Department, Timone Hospital, Assitance Publique Hôpitaux de Marseille, Marseille, France.
National Institute of Health and Medical Research, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France.

Isabelle Lambert (I)

Clinical Neurophysiology and Epileptology Department, Timone Hospital, Assitance Publique Hôpitaux de Marseille, Marseille, France.
National Institute of Health and Medical Research, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France.

Francesca Pizzo (F)

Clinical Neurophysiology and Epileptology Department, Timone Hospital, Assitance Publique Hôpitaux de Marseille, Marseille, France.
National Institute of Health and Medical Research, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France.

Agnès Trébuchon (A)

Clinical Neurophysiology and Epileptology Department, Timone Hospital, Assitance Publique Hôpitaux de Marseille, Marseille, France.
National Institute of Health and Medical Research, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France.

Aileen McGonigal (A)

Clinical Neurophysiology and Epileptology Department, Timone Hospital, Assitance Publique Hôpitaux de Marseille, Marseille, France.
National Institute of Health and Medical Research, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France.

Didier Scavarda (D)

National Institute of Health and Medical Research, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France.
Pediatric Neurosurgery Department, Timone Hospital, Assitance Publique Hôpitaux de Marseille, Marseille, France.

Romain Carron (R)

National Institute of Health and Medical Research, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France.
Functional and Stereotactic Neurosurgery, Assitance Publique Hôpitaux de Marseille, Marseille, France.

Fabrice Bartolomei (F)

Clinical Neurophysiology and Epileptology Department, Timone Hospital, Assitance Publique Hôpitaux de Marseille, Marseille, France.
National Institute of Health and Medical Research, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH